Home
>
National Drug Code (NDC)
>
Benzonatate
Benzonatate - 66116-513-30 - (Benzonatate)
Drug Information of Benzonatate
| Product NDC: | 66116-513 |
| Proprietary Name: | Benzonatate |
| Non Proprietary Name: | Benzonatate |
| Active Ingredient(s): | 200 mg/1 & nbsp; Benzonatate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Benzonatate
| Product NDC: | 66116-513 |
| Labeler Name: | MedVantx, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA081297 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080125 |
Package Information of Benzonatate
| Package NDC: | 66116-513-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (66116-513-30) |
NDC Information of Benzonatate
| NDC Code | 66116-513-30 |
| Proprietary Name | Benzonatate |
| Package Description | 30 CAPSULE in 1 BOTTLE (66116-513-30) |
| Product NDC | 66116-513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benzonatate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080125 |
| Marketing Category Name | ANDA |
| Labeler Name | MedVantx, Inc. |
| Substance Name | BENZONATATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |
